MyoTEC™ System – the percutaneous catheter for myocardial tissue engineering
The MyoTEC™ system is an injection system to deliver Algisyl® or other fluids and viscous fluids (gels) into the heart muscle from the left ventricle (endocardial or inside of the heart) rather than from the outer surface of the heart (epicardial). To accomplish this, a commonly practiced percutaneous technique is used whereby the device is inserted through a small skin opening into an artery. In the case of MyoTEC™, the artery in question (Superficial Femoral Artery) is located in the upper leg in the groin area. From that point of access, the catheter navigates upwards into the ventricle by passing through the aorta, the aortic arch, and the aortic heart valve. The benefit of a percutaneous access is in the ease of introducing devices without the use of large cut downs and chest surgery which require full anesthesia and carry greater post-operative risks.
The MyoTEC™ system consists of the following components at its distal end that are assembled like a telescope and deployed sequentially once the left ventricle is reached:
The MyoTEC™ System is currently being evaluated for clinical use with Algisyl®. Clinical studies in Europe and in the US are expected later in 2017.
CAUTION: Investigational device. Limited by United States law to investigational use only.